Search Results - "Fanti, Stefano"

Reply to “No time like the present: time to rethink our habits in science and continuous medical education?” by Fanti, Stefano

Get full text

Proposal for Systemic-Therapy Response-Assessment Criteria at the Time of PSMA PET/CT Imaging: The PSMA PET Progression Criteria by Fanti, Stefano, Hadaschik, Boris, Herrmann, Ken

“…In around 20% of men with prostate cancer, metastasis develops during the course of their disease. Accordingly, discovering and developing new potent treatment…”
Get full text

E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET by Ceci, Francesco, Oprea-Lager, Daniela E., Emmett, Louise, Adam, Judit A., Bomanji, Jamshed, Czernin, Johannes, Eiber, Matthias, Haberkorn, Uwe, Hofman, Michael S., Hope, Thomas A., Kumar, Rakesh, Rowe, Steven P., Schwarzenboeck, Sarah M., Fanti, Stefano, Herrmann, Ken

“…Rationale The development of consensus guidelines for interpretation of Prostate-Specific Membrane Antigen (PSMA)-Positron Emission Tomography (PET) is needed…”
Get full text

Current status of theranostics in prostate cancer by Virgolini, Irene, Decristoforo, Clemens, Haug, Alexander, Fanti, Stefano, Uprimny, Christian

“…The aim of this review is to report on the current status of prostate-specific membrane antigen (PSMA)-directed theranostics in prostate cancer (PC) patients…”
Get full text

Comments to “Survey by the ANSM of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT” by Giammarile, Francesco, Fanti, Stefano

Get full text

Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer by Fanti, Stefano, Goffin, Karolien, Hadaschik, Boris A, Herrmann, Ken, Maurer, Tobias, MacLennan, Steven, Oprea-Lager, Daniela E., Oyen, Wim JG, Rouvière, Olivier, Mottet, Nicolas, Bjartell, Anders

“…Purpose Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is used for (re)staging prostate cancer (PCa) and…”
Get full text

New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms by Fortunati, Emilia, Argalia, Giulia, Zanoni, Lucia, Fanti, Stefano, Ambrosini, Valentina

“…Opinion statement Neuroendocrine neoplasms (NEN) are a heterogeneous group of tumours derived from cells of neuroendocrine origin and can potentially arise…”
Get full text

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0 by Fendler, Wolfgang P., Eiber, Matthias, Beheshti, Mohsen, Bomanji, Jamshed, Ceci, Francesco, Cho, Steven, Giesel, Frederik, Haberkorn, Uwe, Hope, Thomas A., Kopka, Klaus, Krause, Bernd J., Mottaghy, Felix M., Schöder, Heiko, Sunderland, John, Wan, Simon, Wester, Hans-Jürgen, Fanti, Stefano, Herrmann, Ken

“…The aim of this guideline is to provide standards for the recommendation, performance, interpretation and reporting of 68 Ga-PSMA PET/CT for prostate cancer…”
Get full text

European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma by Taïeb, David, Hicks, Rodney J., Hindié, Elif, Guillet, Benjamin A., Avram, Anca, Ghedini, Pietro, Timmers, Henri J., Scott, Aaron T., Elojeimy, Saeed, Rubello, Domenico, Virgolini, Irène J., Fanti, Stefano, Balogova, Sona, Pandit-Taskar, Neeta, Pacak, Karel

“…Purpose Diverse radionuclide imaging techniques are available for the diagnosis, staging, and follow-up of phaeochromocytoma and paraganglioma (PPGL). Beyond…”
Get full text

METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer by Padhani, Anwar R, Lecouvet, Frederic E, Tunariu, Nina, Koh, Dow-Mu, De Keyzer, Frederik, Collins, David J, Sala, Evis, Schlemmer, Heinz Peter, Petralia, Giuseppe, Vargas, H. Alberto, Fanti, Stefano, Tombal, H. Bertrand, de Bono, Johann

“…Abstract Context Comparative reviews of whole-body magnetic resonance imaging (WB-MRI) and positron emission tomography/computed tomography (CT; with different…”
Get full text

2-[18F]FDG-PET/CT for early response and brain metabolic pattern assessment after CAR-T cell therapy in a diffuse large B cell lymphoma patient with ICANS by Paccagnella, Andrea, Farolfi, Andrea, Casadei, Beatrice, Garibotto, Valentina, Zinzani, Pierluigi, Fanti, Stefano

Get full text

Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline by Trabulsi, Edouard J, Rumble, R Bryan, Jadvar, Hossein, Hope, Thomas, Pomper, Martin, Turkbey, Baris, Rosenkrantz, Andrew B, Verma, Sadhna, Margolis, Daniel J, Froemming, Adam, Oto, Aytekin, Purysko, Andrei, Milowsky, Matthew I, Schlemmer, Heinz-Peter, Eiber, Matthias, Morris, Michael J, Choyke, Peter L, Padhani, Anwar, Oldan, Jorge, Fanti, Stefano, Jain, Suneil, Pinto, Peter A, Keegan, Kirk A, Porter, Christopher R, Coleman, Jonathan A, Bauman, Glenn S, Jani, Ashesh B, Kamradt, Jeffrey M, Sholes, Westley, Vargas, H Alberto

“…Provide evidence- and expert-based recommendations for optimal use of imaging in advanced prostate cancer. Due to increases in research and utilization of…”
Get full text

Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions by Renzulli, Matteo, Brandi, Nicolò, Argalia, Giulia, Brocchi, Stefano, Farolfi, Andrea, Fanti, Stefano, Golfieri, Rita

“…Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide and one of the most common causes of death among patients with…”
Get full text

Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18 F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer by Bach-Gansmo, Tore, Nanni, Cristina, Nieh, Peter T, Zanoni, Lucia, Bogsrud, Tronde Velde, Sletten, Heidi, Korsan, Katrine Andersen, Kieboom, J, Tade, Funmilayo I, Odewole, Oluwaseun, Chau, Albert, Ward, Penelope, Goodman, Mark M, Fanti, Stefano, Schuster, David M, Willoch, Frode

“…Purpose Sensitive detection of cancer foci in men experiencing biochemical recurrence following initial treatment of prostate cancer is of great clinical…”
Get full text

Global Impact of COVID-19 on Nuclear Medicine Departments: An International Survey in April 2020 by Freudenberg, Lutz S, Paez, Diana, Giammarile, Francesco, Cerci, Juliano, Modiselle, Moshe, Pascual, Thomas N B, El-Haj, Noura, Orellana, Pilar, Pynda, Yaroslav, Carrió, Ignasi, Fanti, Stefano, Matushita, Cristina, Herrmann, Ken

“…The coronavirus disease 2019 (COVID-19) pandemic has placed significant challenges on health-care systems worldwide, whether in the preparation, response, or…”
Get full text

Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences by Czernin, Johannes, Fanti, Stefano, Meyer, Philipp T, Allen-Auerbach, Martin, Hacker, Marcus, Sathekge, Mike, Hicks, Rodney, Scott, Andrew M, Hatazawa, Jun, Yun, Mijin, Schöder, Heiko, Bartenstein, Peter, Herrmann, Ken

Get full text

Reliability of molecular imaging diagnostics by Lalumera, Elisabetta, Fanti, Stefano, Boniolo, Giovanni

“…Advanced medical imaging, such as CT, fMRI and PET, has undergone enormous progress in recent years, both in accuracy and utilization. Such techniques often…”
Get full text

Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review by Moris, Lisa, Cumberbatch, Marcus G., Van den Broeck, Thomas, Gandaglia, Giorgio, Fossati, Nicola, Kelly, Brian, Pal, Raj, Briers, Erik, Cornford, Philip, De Santis, Maria, Fanti, Stefano, Gillessen, Silke, Grummet, Jeremy P., Henry, Ann M., Lam, Thomas B.L., Lardas, Michael, Liew, Matthew, Mason, Malcolm D., Omar, Muhammad Imran, Rouvière, Olivier, Schoots, Ivo G., Tilki, Derya, van den Bergh, Roderick C.N., van Der Kwast, Theodorus H., van Der Poel, Henk G., Willemse, Peter-Paul M., Yuan, Cathy Y., Konety, Badrinath, Dorff, Tanya, Jain, Suneil, Mottet, Nicolas, Wiegel, Thomas

“…The optimal treatment for men with high-risk localized or locally advanced prostate cancer (PCa) remains unknown. To perform a systematic review of the…”
Get full text

Salvage therapy for prostate cancer after radical prostatectomy by Zaorsky, Nicholas G., Calais, Jeremie, Fanti, Stefano, Tilki, Derya, Dorff, Tanya, Spratt, Daniel E., Kishan, Amar U.

“…More than 40% of men with intermediate-risk or high-risk prostate cancer will experience a biochemical recurrence after radical prostatectomy. Clinical…”
Get full text

PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma by Zamagni, Elena, Nanni, Cristina, Mancuso, Katia, Tacchetti, Paola, Pezzi, Annalisa, Pantani, Lucia, Zannetti, Beatrice, Rambaldi, Ilaria, Brioli, Annamaria, Rocchi, Serena, Terragna, Carolina, Martello, Marina, Marzocchi, Giulia, Borsi, Enrica, Rizzello, Ilaria, Fanti, Stefano, Cavo, Michele

“…To evaluate the role of 18F-FDG PET/CT in 282 symptomatic multiple myeloma patients treated up-front between 2002 and 2012. All patients were studied by PET/CT…”
Get full text